Dual-port Trans-subclavian Thyroid Endoscopic Surgery
This is a prospective, single-center, open-label, non-randomized controlled real-world study aimed at exploring a novel approach to cavity construction for thyroid endoscopic surgery. The study seeks to evaluate its effectiveness and safety while accumulating further evidence-based medical data. Three hundred patients
| Condition(s) | Thyroid Neoplasms, Endoscopic Surgery |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | This is a prospective, single-center, open-label, non-randomized controlled real-world study aimed at exploring a novel approach to cavity construction for thyroid endoscopic surgery. The study seeks to evaluate its effectiveness and safety while accumulating further evidence-based medical data. Three hundred patients with thyroid tumors were divided into an experimental group (150 cases receiving a new endoscopic thyroid surgery technique, namely, dual-port trans-subclavian thyroid endoscopic surgery) and a control group (150 cases undergoing traditional open thyroid surgery) according to their treatment intention. Laboratory and medical data from specified follow-up points are collected, and adverse events are recorded detailly. The primary efficacy endpoint is a comparison of surgical c |
| Who can participate | Inclusion Criteria: * Thyroid cancer or benign thyroid tumors * Patients with a demand for incisional cosmetic improvement Exclusion Criteria: * Patients with thyroid cancer larger than 2 cm * benign tumors larger than 5 cm * Patients with severe underlying diseases * Patients with chronic kidney disease, * Patients with autoimmune diseases * Patients with rheumatoid arthritis |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Lead sponsor | First Affiliated Hospital of Wenzhou Medical University |
| Locations | Wenzhou, Zhejiang, China |
| Start date | 2022-09-01 |
| NCT ID | NCT06398795 |
| Official listing | https://clinicaltrials.gov/study/NCT06398795 |